What Causes Opioid Withdrawal?
Opioid withdrawal occurs when a person who has developed physical dependence on opioids reduces or stops their use. Physical dependence is a normal biological adaptation that can develop in anyone taking opioids regularly, including patients following prescribed dosing. It is distinct from addiction, which involves compulsive use despite harmful consequences. Physical dependence can be a component of opioid use disorder, but it also commonly occurs with prescribed use and does not mean a person is addicted. The body, having adapted to the constant presence of opioids, reacts to their absence with a constellation of physical and psychological symptoms.
During regular opioid use, the brain reduces its natural production of endorphins (the body's own pain-relieving chemicals) and decreases the number of opioid receptors available. When opioids are suddenly removed, the brain is left in a state of chemical imbalance. It takes time for natural endorphin production and receptor sensitivity to normalize, and the withdrawal symptoms experienced during that period are essentially the brain and body recalibrating.
The severity and duration of withdrawal depend on several factors, including the specific opioid used, the dosage, the duration of use, the method of use (oral, injection, smoking), and individual biological factors like metabolism, age, and overall health. The National Institute on Drug Abuse provides additional research on how opioid dependence develops and what drives withdrawal.
The Opioid Withdrawal Timeline
While every person's experience is different, opioid withdrawal generally follows a predictable pattern. The timeline varies depending on whether the opioid is short-acting (like heroin or immediate-release oxycodone) or long-acting (like methadone or extended-release formulations).
Short-Acting Opioids (Heroin, Oxycodone IR, Hydrocodone)
Hours 6-12: Early Symptoms Begin
Withdrawal from short-acting opioids typically begins within 6 to 12 hours after the last dose. The earliest signs are often subtle and may be mistaken for a cold or flu.
- Anxiety and restlessness
- Muscle aches
- Increased tearing (lacrimation)
- Runny nose (rhinorrhea)
- Excessive yawning
- Sweating
- Difficulty falling asleep
Hours 12-48: Symptoms Intensify
Symptoms escalate significantly during this period. This is often the most difficult phase, and it is when the risk of relapse is highest.
- Nausea and vomiting
- Diarrhea and abdominal cramping
- Dilated pupils
- Goosebumps (piloerection)
- Elevated heart rate and blood pressure
- Intense muscle and bone pain
- Severe insomnia
- Strong drug cravings
- Irritability and agitation
Days 3-5: Peak and Gradual Improvement
Most acute symptoms reach their peak intensity around day 2 or 3 and then begin to slowly subside. Physical symptoms like gastrointestinal distress and muscle pain start to ease, though sleep disruption and mood instability often persist.
Days 5-7+: Resolution of Acute Symptoms
By the end of the first week, the most intense physical symptoms have typically resolved. However, lingering effects are common.
- Fatigue and low energy
- Continued sleep problems
- Reduced appetite
- Mood swings and irritability
- Persistent cravings
- Difficulty concentrating
Long-Acting Opioids (Methadone, Extended-Release Formulations)
Withdrawal from long-acting opioids follows the same general pattern but on a stretched timeline. Symptoms may not begin until 24 to 48 hours after the last dose and can persist for two to three weeks or longer. The peak intensity is usually lower than with short-acting opioids, but the extended duration can be equally challenging.
Withdrawal by Drug Type
Not all opioid withdrawals are the same. The specific drug, its half-life, and its pharmacological profile significantly shape the withdrawal experience. Below is a breakdown of what to expect for the most commonly encountered opioids.
Fentanyl Withdrawal
Fentanyl withdrawal is widely described as among the most intense of all opioid withdrawals. Because illicit fentanyl is extremely potent and accumulates in fatty tissue, withdrawal onset can be unpredictable, sometimes beginning as early as 8 hours after the last dose, sometimes delayed beyond 24 hours. The acute phase is often more severe than heroin withdrawal, with intense muscle and bone pain, extreme agitation, profuse sweating, nausea, diarrhea, overwhelming anxiety, and powerful cravings. The timeline can also be less predictable than other short-acting opioids because of how fentanyl is stored and released from body fat. Medical supervision is strongly recommended for fentanyl withdrawal. For more on the risks of this drug, see our fentanyl guide.
Heroin Withdrawal
Heroin follows the standard short-acting opioid withdrawal timeline: onset within 6 to 12 hours, peak at days 2 to 3, and resolution of acute symptoms within 5 to 7 days. However, much of the heroin supply is now contaminated with or entirely replaced by illicit fentanyl, which can make the withdrawal experience more intense and less predictable than what someone might expect from heroin alone.
Methadone Withdrawal
Methadone has the most prolonged withdrawal of any commonly used opioid. Because of its long half-life, withdrawal onset is delayed, typically 36 to 72 hours after the last dose. The acute phase can last 3 to 6 weeks, significantly longer than short-acting opioids. While the peak intensity may be somewhat lower than heroin or fentanyl withdrawal, the extended duration is extremely challenging and is a major reason people struggle to discontinue methadone. Post-acute symptoms can persist for months. A slow, medically supervised taper is the standard approach for methadone discontinuation.
Buprenorphine (Suboxone/Subutex) Withdrawal
Buprenorphine is itself an opioid, and the body develops physical dependence on it with regular use. This is an important fact that is sometimes downplayed. Stopping buprenorphine abruptly causes real withdrawal symptoms, including muscle aches, insomnia, anxiety, nausea, irritability, and cravings. The intensity is generally milder than full agonist opioid withdrawal, but the duration is prolonged, typically lasting 2 to 4 weeks or longer. A slow, medically supervised taper is the recommended approach for discontinuation. For more on buprenorphine and other medication-based approaches, see our medication-assisted treatment page.
Tramadol Withdrawal
Tramadol withdrawal is unique because the drug has a dual mechanism: it acts as both a weak opioid and an antidepressant (serotonin-norepinephrine reuptake inhibitor). Withdrawal can include standard opioid symptoms plus symptoms of antidepressant discontinuation, such as brain zaps, severe anxiety, confusion, and paranoia. Most significantly, tramadol withdrawal carries an elevated seizure risk that is not typical of other opioid withdrawals. Tramadol should never be stopped abruptly, and medical supervision is essential.
Oxycodone, Hydrocodone, and Codeine Withdrawal
Oxycodone (found in Percocet and OxyContin), hydrocodone (found in Vicodin and Norco), and codeine all follow the standard short-acting opioid withdrawal timeline. Onset is typically 6 to 12 hours after the last dose of immediate-release formulations, with peak symptoms at days 2 to 3 and resolution within 5 to 7 days. Extended-release formulations of oxycodone (OxyContin) may have a slightly delayed onset. The severity depends on dosage and duration of use.
Opioid Withdrawal Comparison Table
| Opioid | Withdrawal Onset | Peak | Acute Duration | Key Characteristics |
|---|---|---|---|---|
| Heroin | 6-12 hours | Days 2-3 | 5-7 days | Classic short-acting timeline, often contaminated with fentanyl |
| Fentanyl (illicit) | 8-24 hours | Days 2-4 | 5-10 days | More intense, unpredictable timeline due to fat storage |
| Oxycodone (IR) | 6-12 hours | Days 2-3 | 5-7 days | Standard short-acting profile |
| Oxycodone (ER) | 12-24 hours | Days 3-4 | 7-10 days | Delayed onset due to extended-release formulation |
| Hydrocodone | 6-12 hours | Days 2-3 | 5-7 days | Similar to oxycodone IR, found in Vicodin and Norco |
| Methadone | 36-72 hours | Days 7-10 | 3-6 weeks | Most prolonged acute withdrawal of any common opioid |
| Buprenorphine/Suboxone | 24-72 hours | Days 3-5 | 2-4+ weeks | Milder intensity but prolonged duration, taper recommended |
| Tramadol | 12-24 hours | Days 2-3 | 5-7 days | Dual withdrawal (opioid + antidepressant), seizure risk |
| Codeine | 6-12 hours | Days 2-3 | 5-7 days | Mildest short-acting opioid withdrawal |
| Morphine | 8-12 hours | Days 2-3 | 5-7 days | Classic opioid withdrawal, moderate to severe intensity |
Post-Acute Withdrawal Syndrome (PAWS)
Some individuals experience a prolonged withdrawal phase known as post-acute withdrawal syndrome (PAWS). This can last for weeks, months, or in some cases over a year after the acute withdrawal phase has ended. PAWS is an important and often underrecognized barrier to sustained recovery.
PAWS symptoms include:
- Anxiety and panic attacks
- Depression
- Sleep disturbances, including insomnia and vivid dreams
- Difficulty experiencing pleasure (anhedonia)
- Cognitive difficulties, including problems with memory and concentration
- Mood swings
- Increased sensitivity to stress
- Persistent, intermittent cravings
PAWS is thought to result from the brain's gradual process of restoring normal function after prolonged opioid exposure. It is an important factor in relapse risk, as many people who successfully complete acute withdrawal are caught off guard by the persistence of these symptoms. Awareness that PAWS is a normal part of recovery can help individuals and their support systems plan accordingly. If you are experiencing PAWS, connecting with ongoing support is essential. Visit our understanding addiction page for more on long-term recovery challenges and our recovery resources page for support groups and crisis lines.
When Is Opioid Withdrawal Dangerous?
Opioid withdrawal is extremely uncomfortable but is rarely life-threatening in otherwise healthy adults. However, there are important exceptions and complications to be aware of.
Dehydration
Severe vomiting and diarrhea can lead to dangerous dehydration and electrolyte imbalances, particularly in people who are already malnourished or have underlying health conditions. In extreme cases, dehydration during opioid withdrawal has been associated with fatal outcomes, particularly in incarcerated settings where medical monitoring is limited.
Aspiration
Vomiting while sedated or in an altered state of consciousness can lead to aspiration pneumonia, which can be fatal. This risk is particularly relevant when withdrawal occurs alongside the use of other sedating substances.
Underlying Medical Conditions
People with heart conditions, respiratory diseases, or other chronic illnesses may experience dangerous complications during withdrawal. Elevated blood pressure and heart rate during peak withdrawal can stress the cardiovascular system.
Pregnancy
Opioid withdrawal during pregnancy is associated with significant risks to the fetus, including premature labor and fetal distress. Pregnant individuals with opioid dependence are generally advised to pursue medication-assisted treatment, typically with methadone or buprenorphine, rather than abrupt withdrawal. For more on MAT, see our medication-assisted treatment page.
Relapse After Withdrawal
One of the most dangerous periods is immediately after completing withdrawal. Tolerance drops rapidly during detox, meaning a dose that was previously tolerated can now cause a fatal overdose. This risk is especially acute when the drug supply contains fentanyl, where dosing is unpredictable. Our fentanyl guide explains why this synthetic opioid has made the overdose landscape far more dangerous. Understanding the connection between withdrawal, relapse, and overdose is critical for anyone in early recovery. See our addiction page for more on relapse prevention.
Inpatient Medical Detox: The Safest Way to Withdraw
Inpatient medical detox is hospital-based withdrawal management under continuous medical supervision, 24 hours a day, 7 days a week. It is the safest setting for opioid withdrawal, particularly for people with severe physical dependence, co-occurring medical or psychiatric conditions, or a history of complicated withdrawal attempts.
How Inpatient Medical Detox Works
Upon admission, the clinical team conducts a comprehensive medical evaluation to assess the severity of dependence, identify co-occurring conditions, and develop a personalized detox protocol. Throughout the detox process, vital signs, hydration, symptom severity, and mental health are monitored continuously.
Medications Used in Inpatient Detox
- Buprenorphine (Subutex, Suboxone) - reduces withdrawal intensity by partially activating opioid receptors. It is important to understand that buprenorphine is itself an opioid, and the body can become physically dependent on it.
- Clonidine - an alpha-2 agonist that manages blood pressure, anxiety, agitation, muscle aches, and sweating
- Anti-nausea medications (ondansetron/Zofran) - controls nausea and vomiting
- Anti-diarrheal medications (loperamide/Imodium) - manages gastrointestinal symptoms
- Non-opioid pain relievers (ibuprofen, naproxen, acetaminophen) - addresses muscle and joint pain
- IV fluids - corrects dehydration and electrolyte imbalances
- Sleep aids (trazodone or other non-addictive options) - addresses insomnia
Duration
Inpatient medical detox typically lasts 5 to 14 days, depending on the opioid involved, the severity of dependence, and individual response to treatment.
Who Is Inpatient Detox For?
- People with severe physical dependence on opioids
- People with co-occurring medical conditions (heart disease, respiratory conditions, diabetes)
- People with co-occurring psychiatric conditions (severe depression, anxiety, suicidal ideation)
- People who have failed prior attempts at outpatient or home detox
- People with unstable housing or living environments not conducive to safe withdrawal
- People withdrawing from fentanyl or high-dose methadone
Important: Detox Is Not Treatment
Inpatient medical detox addresses physical dependence only. It does not treat the underlying behavioral, psychological, and social factors that drive opioid use disorder. Completing detox without transitioning to ongoing care, whether that is medication-assisted treatment, therapy, or a structured recovery program, carries a very high relapse risk. Visit our treatment options page for a full comparison of what comes after detox.
Rapid Detox Under Sedation
Rapid detox under sedation is a hospital-based procedure that compresses the acute withdrawal process into several hours by administering opioid antagonists while the patient is under deep sedation. It is designed for people who want to get through the worst of physical withdrawal without being conscious for the experience.
How Rapid Detox Works
- Pre-admission screening - A thorough medical evaluation determines whether the patient is a safe candidate. This includes cardiac assessment, blood work, and review of medical history.
- Day-before admission - The patient is admitted to the hospital the day before the procedure for preparation and monitoring.
- Procedure under sedation - The patient is placed under deep sedation (not general anesthesia in most modern protocols) and given opioid antagonists (typically naloxone or naltrexone) that force the opioid receptors to clear. The body goes through acute withdrawal while the patient is unconscious.
- Multi-day post-procedure monitoring - The patient remains in the hospital for continued monitoring as sedation wears off and residual withdrawal symptoms are managed.
- Naltrexone initiation - Because the opioid receptors have been cleared, the patient can often begin naltrexone (an opioid blocker) immediately, which is not possible after conventional detox without a longer waiting period.
Who Is Rapid Detox For?
- People with severe anxiety about the withdrawal process
- People who have failed conventional detox attempts
- People who need to begin naltrexone therapy quickly
- People who are medically cleared for the procedure
Risks and Considerations
Rapid detox carries the risks associated with any procedure involving sedation, including respiratory complications and cardiovascular stress. It must be performed in an accredited hospital with full intensive care capabilities, not in a clinic or outpatient setting. Programs that cut corners on medical infrastructure are dangerous.
Cost
Rapid detox under sedation typically costs $10,000 to $15,000 and is rarely covered by insurance. The cost reflects the hospital stay, anesthesia team, medications, and multi-day monitoring.
Important: Aftercare Is Essential
Like all forms of detox, rapid detox addresses physical dependence only. It does not treat addiction. Patients must transition to ongoing care after the procedure. The advantage of rapid detox is that it enables faster initiation of naltrexone, which can support long-term recovery when combined with counseling and support.
For more information on rapid detox programs, visit Waismann Method or rapiddetox.com. For a full comparison of detox and treatment approaches, see our treatment options page.
Precipitated Withdrawal
Precipitated withdrawal is a sudden and severe form of withdrawal that occurs when an opioid antagonist (like naloxone or naltrexone) or a partial agonist (like buprenorphine) is taken while full agonist opioids are still active in the brain. Instead of the gradual onset typical of spontaneous withdrawal, precipitated withdrawal hits within minutes and is significantly more intense.
How It Happens
Buprenorphine has a higher binding affinity for opioid receptors than most full agonist opioids. When taken too soon after the last dose of heroin, fentanyl, or other opioids, buprenorphine displaces the full agonist from the receptors but activates them far less strongly, causing an immediate and dramatic drop in opioid activity. The result is acute withdrawal that peaks within an hour and can last 2 to 4 hours or longer. Naltrexone and naloxone cause precipitated withdrawal through a similar mechanism but with complete receptor blockade rather than partial activation.
How to Avoid Precipitated Withdrawal
- Before starting buprenorphine: Wait until moderate spontaneous withdrawal symptoms are present. For short-acting opioids, this typically means waiting 12 to 24 hours after the last dose. For fentanyl, which accumulates in fatty tissue, an extended wait of 48 to 72 hours or more may be necessary.
- Before starting naltrexone: A minimum of 7 to 10 days after the last opioid use is generally recommended, with confirmation through urine drug screening.
- The Clinical Opiate Withdrawal Scale (COWS) is used by medical professionals to objectively measure withdrawal severity before initiating buprenorphine.
Cannot Be Easily Reversed
Once precipitated withdrawal is triggered, it cannot be easily reversed. Unlike spontaneous withdrawal, which builds gradually and can be managed with medication, precipitated withdrawal is immediate and must largely be endured until the offending medication clears. This is why proper timing of buprenorphine and naltrexone initiation is so important.
Intentional Use in Rapid Detox
Rapid detox under sedation uses precipitated withdrawal intentionally in a controlled hospital setting. By placing the patient under deep sedation before administering the antagonist, the procedure allows the body to go through the intense withdrawal process without the patient being conscious for it. This is the only clinical context in which precipitated withdrawal is deliberately induced.
Neonatal Opioid Withdrawal Syndrome (NOWS)
When a pregnant person uses opioids regularly, the developing baby also develops physical dependence. After birth, when the baby is no longer receiving opioids through the umbilical cord, the newborn can experience withdrawal symptoms. This condition is called Neonatal Opioid Withdrawal Syndrome (NOWS), previously known as Neonatal Abstinence Syndrome (NAS).
Signs of NOWS in Newborns
- High-pitched, excessive crying
- Tremors and increased muscle tone
- Poor feeding and difficulty sucking
- Irritability and difficulty being soothed
- Sleep disturbances
- Sneezing, yawning, and nasal stuffiness
- Vomiting and diarrhea
- Fever
- Seizures (in severe cases)
Treatment
Most cases of NOWS are managed with supportive care: swaddling, skin-to-skin contact, a quiet environment, small frequent feedings, and gentle handling. In more severe cases, the newborn may be given small doses of morphine or methadone on a tapering schedule. Most affected newborns recover fully with appropriate treatment.
Critical: Do Not Stop Opioids Abruptly During Pregnancy
Pregnant people who are physically dependent on opioids should not stop using abruptly. Sudden withdrawal during pregnancy can cause premature labor, fetal distress, and miscarriage. The recommended approach is medically supervised treatment with methadone or buprenorphine, which stabilizes both the mother and the baby. For more on medication-based approaches during pregnancy, see our medication-assisted treatment page.
Breastfeeding and MAT
Breastfeeding is generally encouraged for mothers on stable medication-assisted treatment with methadone or buprenorphine, as the benefits of breastfeeding typically outweigh the very small amounts of medication transferred through breast milk. This decision should be made in consultation with the care team.
Managing Withdrawal Symptoms
Beyond inpatient detox and rapid detox, there are additional approaches to managing opioid withdrawal. The right approach depends on the severity of dependence, overall health, and available resources.
Medication-Assisted Treatment
For many people, the most effective approach is to transition directly from withdrawal management into ongoing medication-assisted treatment with buprenorphine, methadone, or naltrexone. This approach avoids the full intensity of withdrawal while addressing the underlying neurochemical changes that drive opioid use disorder. Visit our treatment options page for a complete overview, or see our dedicated MAT guide for a detailed look at each medication.
Comfort Measures
During withdrawal, staying hydrated, eating small bland meals, taking warm baths, and using heating pads for muscle pain can provide some relief. Maintaining a calm, quiet environment and having a support person present is also beneficial. If you are going through withdrawal alone, the Never Use Alone hotline (1-877-696-1996) provides a phone-based safety service with a trained operator who can dispatch emergency help if needed. Our opioid recovery resources page lists crisis hotlines and support groups that can help during this difficult period.